Abstract
The anti-infectives market is forecast to expand at a CAGR of 4.8%over the
period 2005-11, driven largely by gains in the anti-bacterial and anti-viral
classes. This represents significant market opportunity for pharma companies
to expand their sales potential by targeting high growth markets. ‘The
Global Anti-Infectives Market Outlook to 2011’ provides comprehensive
coverage of the anti-infectives market, incorporating a detailed
epidemiological analysis of the major indications and the key factors
impacting their prevalence. Analysis of the major brands and profiles of the
leading pharmaceutical companies will ensure that you can plan effectively,
evaluate key changes in the competitive landscape, and identify potential
growth areas within the global anti-infectives market. Use this report to
assess anti-infective therapies that will be crucial to maintaining positive
sales growth, analyze the marketed product portfolio and R&D pipelines of the
leading 10 pharmaceutical companies in the global anti-infectives market.